GMS Annual Conference 2026: Advancing Genomics into Clinical Utility – Focus on Rare Diseases, Cancer, and Microbiology

The conference brings together researchers, clinicians, and other key stakeholders in genomic medicine and precision medicine. The aim is to promote knowledge exchange, strengthen collaboration, and support national development in the field.

This year’s conference places a special focus on precision medicine in rare diseases, cancer, and infectious diseases. The program highlights a broad range of key topics, including the development of new technologies, innovative informatics solutions, advanced diagnostic methods, and targeted therapies based on discoveries from basic research.

When: Thursday 8 October 2026

Where: Medicon Village, Lund. 

Registration: further information will follow

Preliminary program:

8.00-8.15 Welcome – a brief look back and an eye to the future. Prof. Richard Rosenqvist Brandell, Director Genomic Medicine Sweden
8.15-9.45

Focus on Cancer – Anders Edsjö, moderator 

  • Keynote
  • Short talks
  • Panel discussion
9.45-10.15 Break – Coffee & Posters
10.15-11.45

Focus on Rare Diseases – Prof. Anna Lindstrand, moderator 

  • Keynote: Prof. Elfride De Baere, University of Gent, Belgium
  • Short talks:
    • Dr Sanna Gudmundsson, Karolinska Institutet
  • Panel discussion
11.45-12.45 Lunch & Posters
12.45-14.15

Focus on Microbiology – Paula Mölling & Tobias Allander, moderators 

  • Keynote: Target Nanopore metagenomic sequencing for rapid precision diagnostics of infections, Prof. Judith Breuer, University College London
  • Short talks:
    • Precision diagnostics with metagenomic analysis and antibiotic resistance prediction, Erika Tång Hallbäck
    • National whole-genome sequencing and real-time data sharing between regions for detection of outbreaks of antibiotic-resistant bacteria, Martin Sundqvist
  • Panel discussion (Judith Breuer, Erika Tång Hallbäck, Martin Sundqvist)
14.15-14.45

Emerging technologies: Focus Long-read Sequencing 

  • Keynote: Christian Gilissen, Radboud University, the Netherlands
14.45-15.15 Super-short highlights from on-going GMS-projects
15.15-15.45 Break – Coffee & Posters
15.45-16.45

International, regional, and patients perspectives 

  • Prof. Etienne Richer, Director Genomics Program, Genome Canada
  • Sofia Gruvberger-Saal, GMC Syd
  • Carolina Vitabäck, patient perspective
16.45-17.00 Final words Prof. Richard Rosenqvist Brandell, Director Genomic Medicine Sweden